In-Person Access Only | 5.00 CE/CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $50 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health, in partnership with the European Society for Medical Oncology (ESMO)—a global authority representing more than 50,000 oncology professionals— is proud to present a state-of-the-art program designed to deliver exclusive U.S.-based updates from the 2026 ESMO Breast Cancer Annual Congress.

This free, 1-day symposium for healthcare providers will spotlight the most important advances across the breast cancer continuum.

Conference Agenda
Saturday, May 16, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome
Cesar Santa-Maria, MD, MSCI | Johns Hopkins University

8:10 AM
Neoadjuvant IO in TNBC
Cesar Santa-Maria, MD, MSCI | Johns Hopkins University

8:30 AM
Escalation vs De-escalation (HER2+, ER+)
Candace Mainor, MD | MedStar Georgetown Lombardi Comprehensive Cancer Center

8:50 AM
MRD/ctDNA in Early Breast Cancer
Sramila Aithal, MD | Alliance Cancer Specialists

9:10 AM
Endocrine Therapy & Next-Gen SERDs
Kashif Ali, MD | Maryland Oncology Hematology

9:30 AM
Breakfast and Exhibits

9:45 AM
Non-CME Breakfast - Natera - Clinical Actionability of Personalized ctDNA Testing in Breast Cancer
Kashif Ali, MD | Maryland Oncology Hematology

10:30 AM
CDK4/6 Inhibitors Across Disease Stages
Jessica Tao, MD | Johns Hopkins University

10:50 AM
HER2-Low and Ultralow Categories (ADC expansion)
Jen Matro, MD | Inova Schar Cancer Center

11:10 AM
Survivorship and QOL
Maryam Lustberg, MD, MPH | Yale Cancer Center

11:30 AM
Emerging ADCs and Novel Targets in Metastatic Disease (e.g. B7‑H4, Trop‑2 ADCs beyond T-DXd)
Coral Omene, MD, PhD| Rutgers Cancer Institute

11:50 AM
Lunch and Exhibits

12:05 PM
Non-CME Lunch - Pfizer - Treatment Considerations for Patients With HR+/HER2- mBC
Sramila Aithal, MD | Alliance Cancer Specialists

12:50 PM
Housekeeping and Survey

1:00 PM
Evolving Paradigms in Metastatic HER2+ Breast Cancer
Cesar Santa-Maria, MD, MSCI | Johns Hopkins University

1:20 PM
Biomarkers Beyond ctDNA: TILs, Immune signatures, Tumor Microenvironment in Breast Cancer
Mohamed Kahila, MBBCh, MD | Yale Cancer Center

1:40 PM
Liquid Biopsy–Guided Therapeutic Escalation (e.g. ESR1 Mutation Detection, Early Switch Strategies)
Adrian Lee, PhD | University of Pittsburgh

2:00 PM
PI3K/AKT Pathway Inhibition: New Agents, Sequencing, Combination Strategies
Marija Balić, MD, PhD | UPMC Magee-Womens Hospital

2:20 PM
Break and Exhibits

2:40 PM
AI / Radiomics / Imaging Biomarkers in Breast Cancer (Predictive Models, Virtual Biopsies)
Lisa Mullen, MD | Johns Hopkins University

3:00 PM
Management of Brain Metastases in HER2+ and Triple-Negative Breast Cancer
Kelly McCann, MD, PhD | UC San Diego

3:20 PM
Special Populations: Pregnancy-Associated Breast Cancer, Male Breast Cancer, BRCA Mutation Carriers
Laila Agrawal, MD | Norton Cancer Institute

3:40 PM
Adjourn

Agenda Subject To Change. All times are EST.

• Learning Objectives

  • Summarize recent advances in the diagnosis, staging, and treatment of breast cancer.

  • Interpret emerging clinical trial data and its implications for current oncology practice.

  • Enhance collaboration across the multidisciplinary cancer care team to improve patient outcomes.

• Accreditation Information | 5.0 CME Credits & MOC Points

  In support of improving patient care, this activity has been planned and implemented by

  Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the

  Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council

  for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses

  Amedco LLC designates this activity for a maximum of 5.00 ANCC contact hours.

  Physicians

  Amedco LLC designates this live activity for a maximum of 5.00 AMA PRA Category 1 CreditsTM for physicians.

  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  
  Pharmacists & Pharmacy Technicians

  Amedco LLC designates this activity for a maximum of 5.00 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Enduring video content for watching at your leisure

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program